• Strategic consortium led by U.S.-based Venture Medical, LLC includes Coöperatie VGZ, Noaber, Stichting Triade, and existing shareholders EIC Fund and Oost NL  • The consortium will invest €6 Million in Plasmacure directly and provide over $10 million in U.S.

Plasmacure offers solution for healing chronic wounds. Plasmacure (Nijmegen/Eindhoven) develops and markets its PLASOMA cold plasma system to better treat chronic wounds. A new series of funding from a consortium with Topfonds Gelderland,

It is wonderful that the EIC Accelerator Grant has been awarded. This enables us to develop a large clinical study to demonstrate the positive effect on the healing of the main types of chronic wounds.

Plasmacure closed a series A round of funding.  The funding was raised with private investors, NextGen Ventures and East Netherlands Development Agency – Oost NL. NextGen Ventures is a fund built primarily on investments by the healthcare insurers Menzis and Friesland Zorgverzekeraar.